Join Our 20,000+ Subscribers. Get Weekly News Sent To Your Email
Subscribe to our newsletter and stay updated on the latest Critical Care Medicine related news.
See Past Critical Care Newsletter issues

Subscribe to Newsletter

Empirical micafungin treatment doesn't improve survival

medicalxpress.com October 8, 2016

Empirical treatment with micafungin seems not to increase invasive fungal infection (IFI)-free survival at 28 days for patients with intensive care unit (ICU)-acquired sepsis with Candida colonization.

infection research sepsis study treatment

Prognostic Predictor Using Lactate-to-Albumin Ratio in Patients with Cirrhosis and Sepsis

Mortality Predictor with sPAP in Elderly Critically Ill with Severe COVID-19 Pneumonia

Low Decent Work Perception Among PICU Nurses

Prognostic Accuracy of POCUS in Patients with Pulseless Electrical Activity

Critical Care Medicine: The Essentials and More

The Language of Kindness

Advances in Critical Care Pediatric Nephrology: Point of Care Ultrasound and Diagnostics

Uncommon Diseases in the ICU

ECMO. Extracorporeal Membrane Oxygenation

Core Curriculum for Pain Management Nursing

Atlas of Chest Imaging in COVID-19 Patients

ICU Protocols: A Step-wise Approach, Vol II

Sepsis: Clinical Diagnosis and Treatment

Fast-Track in Cardiac Anesthesia: Cardiac Surgery in the Era of ERAS

COVID-19 and the Cardiovascular System: From Pathophysiology to Clinical Management

Ethics in Intensive Care Medicine (Lessons from the ICU)

Mechanical Ventilation in Patient with Respiratory Failure

The Infectious Disease Diagnosis: A Case Approach